Senior Pharmacovigilance Consultant
Raphaëlle is a pharmacist and completed her Pharmaceutical education at the University of Châtenay-Malabry, France (Thesis on “Evaluation in vitro of cytokine release by biologics: strategy, involment in product development and risk assessment in humans”). She also had a Master Degree in Human Toxicology, Risk assessment and Vigilance (2012).
Raphaëlle has 4 years of experience in research, including 3 years in pharmaceutical industry in the field of preclinical Toxicology as part of regulatory studies.
She started her professional career in 2011 where she did an internship at “l’Institut Pasteur” within the “Unité de Neurobiologie Intégrative des Systèmes Cholinergiques”. She then participated in the study of the roles of the nicotinic receptors in the addictive properties of nicotine.
In 2012, Raphaëlle joined INSERM Unit 775 “Bases Moléculaires de la Réponse aux Xénobiotiques“ in Paris, for her final internship study, in which she participated to the development of a platform for the detection of product modulating specific hepatic enzyme activities (cytochrome P450).
During these training period, she has acquired a practical and valuable experience in research project management.
In September 2012, Raphaëlle joined the compagny CiToxLAB France as Study Director in Preclinical Toxicology. She is then responsible to the conduct of regulatory toxicology studies in accordance with Good Laboratory Practice. She supports the management of studies including protocols writing, analysis of study data and elaboration of study report.
Through this experience, Raphaëlle developed her expertise in preclinical toxicology, which also contibuted to develop knowledge in quality and regulatory field.
After 3 years of experience in pharmaceutical industry, Raphaëlle moved to consultancy and joined BLUE-REG PHARMA CONSULT in 2015.